New York State Common Retirement Fund’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $486M | Sell |
1,929,503
-98,400
| -5% | -$21.2M | 0.61% | 24 |
|
|
2026
Q1 | $441M | Buy |
2,027,903
+2,400
| +0.1% | +$532K | 0.62% | 20 |
|
|
2025
Q4 | $463M | Sell |
2,025,503
-34,167
| -2% | -$7.78M | 0.62% | 19 |
|
|
2025
Q3 | $477M | Sell |
2,059,670
-129,300
| -6% | -$26.3M | 0.62% | 21 |
|
|
2025
Q2 | $406M | Sell |
2,188,970
-22,300
| -1% | -$4.14M | 0.54% | 24 |
|
|
2025
Q1 | $463M | Sell |
2,211,270
-12,976
| -0.6% | -$2.52M | 0.68% | 22 |
|
|
2024
Q4 | $395M | Buy |
2,224,246
+4,200
| +0.2% | +$772K | 0.53% | 24 |
|
|
2024
Q3 | $438M | Sell |
2,220,046
-139,210
| -6% | -$26M | 0.59% | 22 |
|
|
2024
Q2 | $405M | Sell |
2,359,256
-38,093
| -2% | -$6.31M | 0.53% | 25 |
|
|
2024
Q1 | $437M | Sell |
2,397,349
-131,190
| -5% | -$22.6M | 0.58% | 22 |
|
|
2023
Q4 | $392M | Sell |
2,528,539
-207,477
| -8% | -$30.2M | 0.54% | 24 |
|
|
2023
Q3 | $408M | Sell |
2,736,016
-163,187
| -6% | -$24M | 0.59% | 23 |
|
|
2023
Q2 | $391M | Sell |
2,899,203
-68,791
| -2% | -$10.1M | 0.5% | 27 |
|
|
2023
Q1 | $473M | Sell |
2,967,994
-386,874
| -12% | -$59.1M | 0.63% | 21 |
|
|
2022
Q4 | $542M | Buy |
3,354,868
+6,579
| +0.2% | +$1.01M | 0.74% | 21 |
|
|
2022
Q3 | $449M | Sell |
3,348,289
-143,506
| -4% | -$20.6M | 0.65% | 21 |
|
|
2022
Q2 | $535M | Sell |
3,491,795
-47,341
| -1% | -$7.23M | 0.7% | 21 |
|
|
2022
Q1 | $574M | Buy |
3,539,136
+1,981
| +0.1% | +$288K | 0.61% | 20 |
|
|
2021
Q4 | $479M | Sell |
3,537,155
-16,258
| -0.5% | -$1.92M | 0.48% | 31 |
|
|
2021
Q3 | $383M | Sell |
3,553,413
-243,090
| -6% | -$27.8M | 0.41% | 43 |
|
|
2021
Q2 | $428M | Sell |
3,796,503
-75,539
| -2% | -$8.51M | 0.44% | 36 |
|
|
2021
Q1 | $419M | Buy |
3,872,042
+52,149
| +1% | +$5.58M | 0.46% | 34 |
|
|
2020
Q4 | $409M | Sell |
3,819,893
-785
| -0% | -$75.4K | 0.46% | 33 |
|
|
2020
Q3 | $335M | Sell |
3,820,678
-179,490
| -4% | -$16.9M | 0.41% | 43 |
|
|
2020
Q2 | $393M | Buy |
4,000,168
+624,191
| +18% | +$55M | 0.5% | 32 |
|
|
2020
Q1 | $257M | Sell |
3,375,977
-10,473
| -0.3% | -$892K | 0.39% | 51 |
|
|
2019
Q4 | $300M | Sell |
3,386,450
-62,155
| -2% | -$5.16M | 0.36% | 52 |
|
|
2019
Q3 | $261M | Sell |
3,448,605
-9,783
| -0.3% | -$671K | 0.33% | 55 |
|
|
2019
Q2 | $251M | Sell |
3,458,388
-117,748
| -3% | -$9.25M | 0.32% | 55 |
|
|
2019
Q1 | $288M | Buy |
3,576,136
+87,849
| +3% | +$7.19M | 0.37% | 51 |
|
|
2018
Q4 | $322M | Sell |
3,488,287
-206,379
| -6% | -$18.1M | 0.47% | 36 |
|
|
2018
Q3 | $349M | Sell |
3,694,666
-205,150
| -5% | -$19.5M | 0.41% | 41 |
|
|
2018
Q2 | $361M | Sell |
3,899,816
-159,130
| -4% | -$15.5M | 0.45% | 35 |
|
|
2018
Q1 | $384M | Sell |
4,058,946
-104,830
| -3% | -$11.5M | 0.48% | 33 |
|
|
2017
Q4 | $403M | Buy |
4,163,776
+9,000
| +0.2% | +$848K | 0.48% | 37 |
|
|
2017
Q3 | $369M | Buy |
4,154,776
+17,195
| +0.4% | +$1.31M | 0.47% | 37 |
|
|
2017
Q2 | $300M | Sell |
4,137,581
-57,601
| -1% | -$3.87M | 0.4% | 41 |
|
|
2017
Q1 | $273M | Buy |
4,195,182
+45,806
| +1% | +$2.88M | 0.37% | 42 |
|
|
2016
Q4 | $260M | Sell |
4,149,376
-94,800
| -2% | -$5.79M | 0.37% | 45 |
|
|
2016
Q3 | $268M | Sell |
4,244,176
-11,024
| -0.3% | -$714K | 0.39% | 45 |
|
|
2016
Q2 | $263M | Buy |
4,255,200
+101,900
| +2% | +$6.21M | 0.38% | 46 |
|
|
2016
Q1 | $237M | Sell |
4,153,300
-164,522
| -4% | -$9.17M | 0.36% | 51 |
|
|
2015
Q4 | $256M | Sell |
4,317,822
-325,900
| -7% | -$18.8M | 0.39% | 47 |
|
|
2015
Q3 | $253M | Buy |
4,643,722
+91,385
| +2% | +$5.95M | 0.4% | 46 |
|
|
2015
Q2 | $306M | Buy |
4,552,337
+173,513
| +4% | +$11.3M | 0.45% | 38 |
|
|
2015
Q1 | $256M | Sell |
4,378,824
-11,996
| -0.3% | -$725K | 0.37% | 49 |
|
|
2014
Q4 | $287M | Sell |
4,390,820
-115,526
| -3% | -$7.28M | 0.43% | 40 |
|
|
2014
Q3 | $260M | Buy |
4,506,346
+10,684
| +0.2% | +$593K | 0.39% | 42 |
|
|
2014
Q2 | $254M | Sell |
4,495,662
-10,525
| -0.2% | -$552K | 0.37% | 45 |
|
|
2014
Q1 | $232M | Buy |
4,506,187
+3,025
| +0.1% | +$153K | 0.36% | 49 |
|
|
2013
Q4 | $238M | Sell |
4,503,162
-126,400
| -3% | -$6.21M | 0.37% | 45 |
|
|
2013
Q3 | $207M | Sell |
4,629,562
-179,400
| -4% | -$7.95M | 0.35% | 51 |
|
|
2013
Q2 | $199M | Buy |
+4,808,962
| New | +$210M | 0.35% | 51 |
|
Other funds holding ABBV
ECSS
New York State Common Retirement Fund's ABBV Position: Q2 2026 in Review
New York State Common Retirement Fund reduced its AbbVie (ABBV) stake by 4.9% in Q2 2026, selling an estimated $21.2M and leaving 1,929,503 shares worth $486M. The position accounts for 0.61% of the portfolio, ranked #24.
New York State Common Retirement Fund first reported a position in ABBV in Q2 2013 and has held it in 53 quarters since. The position peaked at $574M in Q1 2022. 2,236 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- New York State Common Retirement Fund held 1,929,503 shares of AbbVie worth $486M as of Q2 2026.
- New York State Common Retirement Fund sold 98,400 AbbVie shares in Q2 2026, an estimated $21.2M.
- AbbVie made up 0.61% of New York State Common Retirement Fund's portfolio in Q2 2026, its #24 holding.
- New York State Common Retirement Fund first reported a position in AbbVie in Q2 2013 and has held it in 53 quarters since.
- New York State Common Retirement Fund's AbbVie position peaked at $574M in Q1 2022.
- 2,236 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on New York State Common Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.